Viewing Study NCT03565003


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2025-12-25 @ 5:01 PM
Study NCT ID: NCT03565003
Status: COMPLETED
Last Update Posted: 2024-09-25
First Post: 2018-05-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module